Cutting edge and innovative genetic-based approach to patient relevant research
Research
The Section has a wide and varied research portfolio that extends from basic bench-focused studies of disease pathogenesis and target gene validation to human-based studies of clinical issues such as cognitive impairment in the MICU. A unifying theme amongst the bench focused investigators is the desire to elucidate the cellular and molecular events involved in lung injury and repair. The result has been an intense focus on immunology and molecular biology and the development of scientific approaches at Yale that are now used through out the world. The investigators and their programs are highlighted below.
Research Areas
Genomics and Genetics Translational Lung Biology Transformation of basic science discoveries into goal-oriented translational researchOutcomes and Biomarkers Clinical-based patient-oriented outcome researchImmunobiology of Lung Disease Study of the role of immune cells in multiple advanced lung diseasesLung Fibrosis and Repair Investigations on the mechanisms of lung fibrosis and repairLung Injury and Inflammation Research on mechanisms of lung injury and inflammationAging Focus on the molecular and cellular changes in the lung with agingHost-Pathogen Interaction Study of the interaction between microbial pathogens and the hostNovel Therapeutics Development of new therapeutics for lung diesases, critical care illness and sleep disordersResearch in COPD Pulmonary Vascular Research Critical Care Research